Wendy L Dixon
CIK 1202283 · Auf SEC EDGAR ansehen ↗
Insider
Erste SEC-Einreichung: 12. Juli 2010 · Neueste: 12. Juli 2010
Auf dieser Seite
- Insider bei Unternehmen, bei denen diese Person ein meldepflichtiger Insider ist.
- Insider-Transaktionen Jede Aktie, die diese Person gekauft oder verkauft hat, aus Formular 4-Einreichungen.
- Derivate Options- und andere Derivatebestände, die von dieser Person gemeldet werden.
- Anfängliche Bestände Die Beteiligungen, die diese Person hielt, als sie mit der Berichterstattung begann.
Insider bei
Insider-Transaktionen
0 Käufe (P)
0 Verkäufe (S)
Netto:
$0
+ 92 nicht börsennotierte Transaktionen unten
letzte 12 Monate, basierend auf den unten gezeigten Transaktionen
Preisänderung im Vergleich zum aktuellen Kurs, bereinigt um Aktiensplits und Unternehmensmaßnahmen seit der Einreichung – nicht benchmarkt, nicht annualisiert, nicht größen-gewichtet
92 weitere Einreichungen ausgeblendet
| Date | Ticker | Code | Aktien | Kurs | Wert | Besessen danach | Δ Eigenbesitz | A/D | vs jetzt |
|---|---|---|---|---|---|---|---|---|---|
| 23. Dezember 2021 | INCY | S 10b5-1 | 20.000 | $22,05 | $441.000 | 17.259 Direkt | -53,68% | Veräußert | 478,5% (Preis per 2026-08-21) |
| 10. Juni 2021 | ALKS | S 10b5-1 | 25.000 | $25,00 | $625.000 | 41.300 Direkt | -37,71% | Veräußert | 92,3% (Preis per 2026-08-21) |
| 19. April 2021 | ALKS | S 10b5-1 | 25.000 | $20,00 | $500.000 | 36.600 Direkt | -40,58% | Veräußert | 140,3% (Preis per 2026-08-21) |
| 27. August 2020 | INCY | S | 20.000 | $94,51 | $1.890.200 | 14.243 Direkt | -58,41% | Veräußert | 35,0% (Preis per 2026-08-21) |
| 8. November 2019 | INCY | S | 18.334 | $83,87 | $1.537.673 | 12.340 Direkt | -59,77% | Veräußert | 52,1% (Preis per 2026-08-21) |
| 8. November 2019 | INCY | S | 22.884 | $83,87 | $1.919.281 | 12.340 Direkt | -64,97% | Veräußert | 52,1% (Preis per 2026-08-21) |
| 7. November 2019 | INCY | S | 1.540 | $83,60 | $128.744 | 12.340 Direkt | -11,10% | Veräußert | 52,6% (Preis per 2026-08-21) |
| 6. November 2019 | INCY | S | 10.576 | $84,16 | $890.076 | 12.340 Direkt | -46,15% | Veräußert | 51,6% (Preis per 2026-08-21) |
Zeige die neuesten 100 von 182 Transaktionen
K = Kauf auf offener Markt · V = Verkauf · A = Zuteilung/Auszeichnung · M = Optionsausübung · G = Geschenk · F = Steuereinbehalt
Insider-Transaktionen sind keine Empfehlung; Verkäufe werden oft aus Liquiditäts- oder steuerlichen Gründen getätigt.
Derivate-Bestände (Formular 4 Tabelle II)
Optionen, RSUs und wandelbare Wertpapiere, die in Formular 4 Tabelle II gemeldet werden.
| Date | Ticker | Wertpapier | Basiswert | Ausübungspreis | Verfall | Aktien | A/D |
|---|---|---|---|---|---|---|---|
| 16. Mai 2023 | BDTX | Stock Option (Right to Buy) | Common Stock (16.500) | $1,82 | 15. Mai 2033 | 16.500 | Erworben |
| 16. Juni 2022 | ARVN | Stock Option (right to buy) | Common Stock (10.192) | $36,79 | 15. Juni 2032 | 10.192 | Erworben |
| 14. Juni 2022 | ALKS | Restricted Stock Unit Award | Ordinary Shares (7.585) | — | — | 7.585 | Veräußert |
| 10. Juni 2022 | IOVA | Deferred Restricted Stock Unit | Common Stock (51.204) | — | — | 51.204 | Erworben |
| 10. Juni 2022 | BDTX | Stock Option (Right to Buy) | Common Stock (15.000) | $2,14 | 9. Juni 2032 | 15.000 | Erworben |
| 6. April 2022 | BDTX | Stock Option (Right to Buy) | Common Stock (30.000) | $3,04 | 5. April 2032 | 30.000 | Erworben |
| 23. Dezember 2021 | INCY | Non Qualfied Stock Option (right to buy) | Common Stock (20.000) | $73,25 | 29. Mai 2022 | 20.000 | Veräußert |
| 2. Dezember 2021 | ALKS | Restricted Stock Unit Award | Ordinary Shares (5.578) | — | — | 5.578 | Veräußert |
| 14. Juni 2021 | ALKS | Restricted Stock Unit Award | Ordinary Shares (7.585) | — | — | 7.585 | Erworben |
| 14. Juni 2021 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (15.677) | $24,72 | 14. Juni 2031 | 15.677 | Erworben |
| 10. Juni 2021 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (25.000) | $18,21 | 1. August 2022 | 25.000 | Veräußert |
| 8. Juni 2021 | ARVN | Stock Option (right to buy) | Common Stock (7.511) | $78,53 | 7. Juni 2021 | 7.511 | Erworben |
| 26. Mai 2021 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (8.010) | $83,16 | 25. Mai 2031 | 8.010 | Erworben |
| 20. Mai 2021 | ALKS | Restricted Stock Unit Award | Ordinary Shares (6.104) | $0,00 | — | 6.104 | Veräußert |
| 19. April 2021 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (25.000) | $14,60 | 5. Oktober 2021 | 25.000 | Veräußert |
| 13. Januar 2021 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (20.000) | $12,62 | 13. Januar 2021 | 20.000 | Veräußert |
| 13. Januar 2021 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (15.000) | $12,62 | 13. Januar 2021 | 15.000 | Veräußert |
| 2. Dezember 2020 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (11.509) | $18,82 | 2. Dezember 2030 | 11.509 | Erworben |
| 2. Dezember 2020 | ALKS | Restricted Stock Unit Award | Ordinary Shares (5.578) | $0,00 | — | 5.578 | Erworben |
| 27. August 2020 | INCY | Non Qualfied Stock Option (right to buy) | Common Stock (20.000) | $18,97 | 19. Mai 2021 | 20.000 | Veräußert |
| 29. Juni 2020 | ARVN | Stock Option (right to buy) | Common Stock (24.000) | $31,95 | 28. Juni 2030 | 24.000 | Erworben |
| 4. Juni 2020 | VYGR | Stock Option (Right to Buy) | Common Stock (15.000) | $11,79 | 4. Juni 2030 | 15.000 | Erworben |
| 26. Mai 2020 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (10.514) | $98,68 | 25. Mai 2030 | 10.514 | Erworben |
| 20. Mai 2020 | ALKS | Restricted Stock Unit Award | Ordinary Shares (6.104) | $0,00 | — | 6.104 | Erworben |
| 20. Mai 2020 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (12.823) | $16,85 | 20. Mai 2030 | 12.823 | Erworben |
| 8. November 2019 | INCY | Non Qualfied Stock Option (right to buy) | Common Stock (18.334) | $12,46 | 21. Mai 2020 | 18.334 | Veräußert |
| 8. November 2019 | INCY | Non Qualfied Stock Option (right to buy) | Common Stock (22.884) | $12,46 | 21. Mai 2020 | 22.884 | Veräußert |
| 7. November 2019 | INCY | Non Qualfied Stock Option (right to buy) | Common Stock (1.540) | $12,46 | 21. Mai 2020 | 1.540 | Veräußert |
| 6. November 2019 | INCY | Non Qualfied Stock Option (right to buy) | Common Stock (10.576) | $12,46 | 21. Mai 2020 | 10.576 | Veräußert |
| 13. Juni 2019 | VYGR | Stock Option (Right to Buy) | Common Stock (15.000) | $24,68 | 13. Juni 2029 | 15.000 | Erworben |
| 22. Mai 2019 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (22.400) | $25,04 | 22. Mai 2029 | 22.400 | Erworben |
| 26. April 2019 | INCY | Employee Stock Option (right to buy) | Common Stock (12.472) | $75,03 | 25. April 2029 | 12.472 | Erworben |
| 14. Juni 2018 | VYGR | Stock Option (Right to Buy) | Common Stock (15.000) | $21,64 | 14. Juni 2028 | 15.000 | Erworben |
| 23. Mai 2018 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (17.500) | $45,64 | 23. Mai 2028 | 17.500 | Erworben |
| 1. Mai 2018 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (15.000) | $60,85 | 30. April 2028 | 15.000 | Erworben |
| 29. Juni 2017 | VYGR | Stock Option (Right to Buy) | Common Stock (15.000) | $9,06 | 29. Juni 2027 | 15.000 | Erworben |
| 26. Mai 2017 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (15.000) | $134,38 | 25. Mai 2027 | 15.000 | Erworben |
| 24. Mai 2017 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (14.200) | $58,25 | 24. Mai 2027 | 14.200 | Erworben |
| 3. Januar 2017 | VYGR | Stock Option (Right to Buy) | Common Stock (30.000) | $11,97 | 3. Januar 2027 | 30.000 | Erworben |
| 27. Mai 2016 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (15.000) | $84,53 | 26. Mai 2026 | 15.000 | Erworben |
| 25. Mai 2016 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (21.600) | $43,58 | 25. Mai 2026 | 21.600 | Erworben |
| 27. Mai 2015 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (16.000) | $60,57 | 27. Mai 2025 | 16.000 | Erworben |
| 22. Mai 2015 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (15.000) | $107,69 | 21. Mai 2025 | 15.000 | Erworben |
| 28. Mai 2014 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (25.000) | $45,74 | 28. Mai 2024 | 25.000 | Erworben |
| 28. Mai 2014 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (15.000) | $49,01 | 27. Mai 2024 | 15.000 | Erworben |
| 1. August 2013 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (25.000) | $33,68 | 1. August 2023 | 25.000 | Erworben |
| 30. Mai 2013 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (20.000) | $22,74 | 29. Mai 2023 | 20.000 | Erworben |
| 1. August 2012 | ALKS | Non Qualified Stock Option (Right to Buy) | Ordinary Shares (25.000) | $18,21 | 1. August 2022 | 25.000 | Erworben |
| 30. Mai 2012 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (20.000) | $22,05 | 29. Mai 2022 | 20.000 | Erworben |
| 5. Oktober 2011 | ALKS | Non Qualified Stock Option (Right to Buy) | Common Stock (25.000) | $14,60 | 5. Oktober 2021 | 25.000 | Erworben |
| 16. September 2011 | ALKS | Non Qualified Stock Option (Right to Buy) | Common Stock (20.000) | $12,62 | 13. Januar 2021 | 20.000 | Erworben |
| 16. September 2011 | ALKS | Non Qualified Stock Option (Right to Buy) | Common Stock (15.000) | $12,62 | 13. Januar 2021 | 15.000 | Erworben |
| 20. Mai 2011 | INCY | Non-Qualified Stock Options (right to buy) | Common Stock (20.000) | $18,97 | 19. Mai 2021 | 20.000 | Erworben |
| 8. Juli 2010 | XRAY | Additional RSUs [F1] | Common Stock (7) | $31,03 | — | 7 | Erworben |
| 28. Juni 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (8) | $31,11 | — | 8 | Erworben |
| 21. Mai 2010 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (18.334) | $12,46 | 20. Mai 2020 | 18.334 | Erworben |
| 21. Mai 2010 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (35.000) | $12,46 | 20. Mai 2020 | 35.000 | Erworben |
| 6. April 2010 | XRAY | Additional RSUs [F1] | Common Stock (5) | $34,17 | — | 5 | Erworben |
| 24. März 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (8) | — | — | 8 | Erworben |
| 9. Januar 2010 | XRAY | Additional RSUs [F1] | Common Stock (4) | $35,44 | — | 4 | Erworben |
| 18. Dezember 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (7) | — | — | 7 | Erworben |
| 6. Oktober 2009 | XRAY | Phantom Stock (Deferred Compensation) | Common Stock (7) | $34,64 | — | 7 | Erworben |
| 6. Oktober 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $33,60 | — | 5 | Erworben |
| 7. Juli 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $30,93 | — | 5 | Erworben |
| 22. Juni 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (9) | $29,27 | — | 9 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.053) | $29,70 | 12. Mai 2019 | 3.053 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.054) | $29,70 | 12. Mai 2019 | 3.054 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.053) | $29,70 | 12. Mai 2019 | 3.053 | Erworben |
| 12. Mai 2009 | XRAY | Restricted Stock Unit | Common Stock (1.343) | — | — | 1.343 | Erworben |
| 8. April 2009 | XRAY | Additional RSUs [F1] | Common Stock (3) | $27,50 | — | 3 | Erworben |
| 18. März 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (10) | $24,84 | — | 10 | Erworben |
| 9. Januar 2009 | XRAY | Additional RSUs [F1] | Common Stock (3) | $26,50 | — | 3 | Erworben |
| 17. Dezember 2008 | XRAY | Director's Deferred Comp - Phantom Stock | Common Stock (530) | $26,83 | — | 530 | Erworben |
| 7. Oktober 2008 | XRAY | Additional RSUs [F1] | Common Stock (2) | — | — | 2 | Erworben |
| 6. Oktober 2008 | XRAY | Phantom Stock (3Q2008 Deferred Compensation) | Common Stock (420) | $34,94 | — | 420 | Erworben |
| 28. Juli 2008 | XRAY | Director Stock Option | Common Stock (399) | $39,39 | 28. Juli 2018 | 399 | Erworben |
| 28. Juli 2008 | XRAY | Director Stock Option | Common Stock (398) | $39,39 | 28. Juli 2018 | 398 | Erworben |
| 28. Juli 2008 | XRAY | Director Stock Option | Common Stock (399) | $39,39 | 28. Juli 2018 | 399 | Erworben |
| 28. Juli 2008 | XRAY | Director RSU July 2008 | Common Stock (174) | — | — | 174 | Erworben |
| 8. Juli 2008 | XRAY | Additional RSUs [F1] | Common Stock (2) | — | — | 2 | Erworben |
| 1. Juli 2008 | XRAY | Director Stock Option | Common Stock (1.543) | $37,17 | 1. Juli 2018 | 1.543 | Erworben |
| 1. Juli 2008 | XRAY | Director Stock Option | Common Stock (1.543) | $37,17 | 1. Juli 2018 | 1.543 | Erworben |
| 1. Juli 2008 | XRAY | Director Stock Option | Common Stock (1.543) | $37,17 | 1. Juli 2018 | 1.543 | Erworben |
| 24. Juni 2008 | XRAY | Phantom Stock (2Q2008 Deferred Compensation) | Common Stock (306) | $38,09 | — | 306 | Erworben |
| 13. Mai 2008 | XRAY | Stock Option | Common Stock (138) | $41,07 | 13. Mai 2018 | 138 | Erworben |
| 13. Mai 2008 | XRAY | Stock Option | Common Stock (138) | $41,07 | 13. Mai 2018 | 138 | Erworben |
| 13. Mai 2008 | XRAY | Stock Option | Common Stock (138) | $41,07 | 13. Mai 2018 | 138 | Erworben |
| 13. Mai 2008 | XRAY | Director RSU May 2008 | Common Stock (760) | — | — | 760 | Erworben |
| 7. April 2008 | XRAY | Additional RSUs [F1] | Common Stock (1) | — | — | 1 | Erworben |
| 27. März 2008 | XRAY | Phantom Stock (1Q2008 Deferred Compensation) | Common Stock (4) | $38,41 | — | 4 | Erworben |
| 27. März 2008 | XRAY | Phantom Stock (1Q2008 Deferred Compensation) | Common Stock (369) | $38,41 | — | 369 | Erworben |
| 8. Januar 2008 | XRAY | Additional RSUs [F1] | Common Stock (1) | — | — | 1 | Erworben |
| 21. Dezember 2007 | XRAY | Phantom Stock (4Q2007 Deferred Compensation) | Common Stock (3.504) | $44,21 | — | 3.504 | Erworben |
| 9. Oktober 2007 | XRAY | Additional RSUs [F1] | Common Stock (1) | — | — | 1 | Erworben |
| 31. Juli 2007 | XRAY | Director Stock Option | Common Stock (160) | $36,49 | 31. Juli 2017 | 160 | Erworben |
| 31. Juli 2007 | XRAY | Director Stock Option | Common Stock (161) | $36,49 | 31. Juli 2017 | 161 | Erworben |
| 31. Juli 2007 | XRAY | Director Stock Option | Common Stock (160) | $36,49 | 31. Juli 2017 | 160 | Erworben |
| 31. Juli 2007 | XRAY | Director RSU July 2007 | Common Stock (863) | — | — | 863 | Erworben |
| 7. März 2006 | BMY | Executive Option (right to buy) | Common Stock, $0.10 par value (37.145) | $22,73 | 6. März 2016 | 37.145 | Erworben |
| 1. Juli 2005 | XRAY | Stock Option | Common Stock (3.333) | $54,14 | 1. Juli 2015 | 3.333 | Erworben |
Zeige die neuesten 100 von 104 Transaktionen
Ausübungs-/Umwandlungspreis ist leer, wenn nicht zutreffend (z. B. RSUs).
Anfänglicher Besitz (Formular 3) 1 Beteiligung
Wertpapiere, die beim erstmaligen Eintritt als Insider gehalten wurden, gemäß SEC Formular 3.
| Date | Ticker | Wertpapier | Aktien | Besitz |
|---|---|---|---|---|
| 18. Februar 2021 | ARVN | Common Stock | — | Direkt |